Skip to content
BIO Launches ‘Fight of Our Lives’: The Real Stories, Power, and Promise of American Biotech at a Defining Moment
At some point in our lives, many of us will find ourselves in a health fight we didn’t expect. A diagnosis. A test result. […]
Poll: U.S. voters want PBM and insurance reform—and strong biotech
Voters see a better path than Most Favored Nation to ensure access and affordability of innovative medicines Eight in 10 American voters would be
Poll: U.S. voters want PBM and insurance reform—and strong biotech Read More »
The hidden layer of PBMs: What a recent investigation reveals
With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working
The hidden layer of PBMs: What a recent investigation reveals Read More »
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care
Americans are frustrated with the health care system for two reasons. First, it costs too much. But—second—it provides too little. While most of the
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care Read More »
Putting Americans First: Importing European prices means importing European systems and values
European countries don’t just pull prices for medicines out of thin air. The prices that those governments set are based on specific sets of
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is
Putting Americans First: International prices in context Read More »
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
The biotech-focused provisions in the reconciliation bill prioritize R&D, patient affordability
The One Big Beautiful Bill Act – the “reconciliation bill” being considered by Congress – features policies that are crucial for driving American innovation.
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America
“This is America,” goes the musical refrain of the new Hims & Hers Super Bowl ad for its compounded obesity drugs. But Hims &
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America Read More »
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand the issue clearly. In
Combatting misinformation on biotechnology in food Read More »